AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.9784
-0.0066 (-0.67%)
Apr 1, 2026, 4:00 PM EDT - Market closed
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $24.76 million as of April 1, 2026. Its market cap has increased by 2,871.87% in one year.
Market Cap
24.76M
Enterprise Value
57.24M
1-Year Change
2,871.87%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $24.76M, a decrease of -61.11%. That is a compound annual growth rate of -17.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 24.76M | 90.11% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | 63.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 27.24M |
| Quantum BioPharma | 27.08M |
| BriaCell Therapeutics | 27.02M |
| Daré Bioscience | 26.64M |
| Dyadic International | 26.60M |
| Kyntra Bio | 26.14M |
| Jasper Therapeutics | 25.19M |
| CEL-SCI | 24.85M |